Lim, Elgene
Garvan Institute of Medical Research · UNSW Sydney · St Vincent's Hospital Sydney · The Kinghorn Cancer Centre
7 papers on CoChatORCID 0000-0001-8065-8838
Most cited papers
- Verified
A single-cell and spatially resolved atlas of human breast cancers
Wu, S. Z., Al-Eryani, G., Roden, D. L., Junankar, S., Harvey, K., Andersson, A., Thennavan, A., Wang, C., Torpy, J. R., Bartonicek, N., et al. (2021) · Nature Genetics
Single-cell and spatial transcriptomicsBreast Cancer Treatment Studies
Cited by 1,775
- Verified
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
kConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine
BRCA gene mutations in cancerCancer Cells and Metastasis
Cited by 1,492
- Verified
ROAST: rotation gene set tests for complex microarray experiments
Wu, D., Lim, E., Vaillant, F., Asselin-Labat, M.-L., Visvader, J. E., & Smyth, G. K. (2010) · Bioinformatics
Bioinformatics and Genomic NetworksGene expression and cancer classification
Cited by 560
- Verified
Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways
Lim, E., Wu, D., Pal, B., Bouras, T., Asselin-Labat, M.-L., Vaillant, F., Yagita, H., Lindeman, G. J., Smyth, G. K., & Visvader, J. E. (2010) · Breast Cancer Research
Cancer Cells and MetastasisBreast Cancer Treatment Studies
Cited by 440
- Verified
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications
Hedgehog Signaling Pathway StudiesCancer Cells and Metastasis
Cited by 437
- Verified
Clinical Overview of MDM2/X-Targeted Therapies
Burgess, A., Chia, K. M., Haupt, S., Thomas, D., Haupt, Y., & Lim, E. (2016) · Frontiers in Oncology
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 315
- Verified
CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA Wild-Type and mutated models of Triple-Negative breast Cancer
Johnson, S. F., Cruz, C., Greifenberg, A. K., Dust, S., Stover, D. G., Chi, D., Primack, B., Cao, S., Bernhardy, A. J., Coulson, R., et al. (2016) · Cell Reports
PARP inhibition in cancer therapyAdvanced Breast Cancer Therapies
Cited by 291
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free